美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=FLUTICASONE PROPIONATE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE 203433 002 ANDA FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE POWDER;INHALATION 0.25MG/INH;EQ 0.05MG BASE/INH No No 2020/12/17 2020/12/17 HIKMA Prescription
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE 203433 003 ANDA FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE POWDER;INHALATION 0.5MG/INH;EQ 0.05MG BASE/INH No No 2020/12/17 2023/12/19 HIKMA Prescription
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE 208111 001 ANDA AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE SPRAY, METERED;NASAL 0.137MG/SPRAY;0.05MG/SPRAY No No 2021/02/18 2021/02/18 PADAGIS ISRAEL Prescription
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE 213948 001 ANDA FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE POWDER;INHALATION 0.1MG/INH;EQ 0.05MG BASE/INH No No 2021/12/13 2021/12/13 TEVA PHARMS USA Prescription
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE 213948 002 ANDA FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE POWDER;INHALATION 0.25MG/INH;EQ 0.05MG BASE/INH No No 2021/12/13 2021/12/13 TEVA PHARMS USA Prescription
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE 213948 003 ANDA FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE POWDER;INHALATION 0.5MG/INH;EQ 0.05MG BASE/INH No No 2021/12/13 2021/12/13 TEVA PHARMS USA Prescription
FLUTICASONE PROPIONATE 215343 001 ANDA FLUTICASONE PROPIONATE OINTMENT;TOPICAL 0.005% No No 2023/09/01 2023/09/01 BRIGHT Discontinued
FLUTICASONE PROPIONATE 217088 001 ANDA FLUTICASONE PROPIONATE SPRAY, METERED;NASAL 0.05MG/SPRAY No No 2024/05/10 2024/05/10 AUROBINDO PHARMA LTD Over-the-counter
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database